Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2018-10-24, Stock:LLY, The news for the past five days is as follows:
2018-10-17: NEWS1: Health Care Sector Update for 10/17/2018: TEVA,ESRX,AMGN,NVW,LLY,VTVT,KDMN,FMS.NEWS2: Health Care Sector Update for 10/17/2018: TEVA,ESRX,AMGN,NVW,LLY,VTVT,KDMN,FMS.NEWS3: Exclusive: Express Scripts covers Amgen, Lilly migraine drugs, excludes Teva.NEWS4: Express Scripts covers Amgen, Lilly migraine drugs, excludes Teva.NEWS5: Stocks - Netflix Soars in Pre-market; IBM, Tilray, Canopy Growth Sink; Tesla Rises.NEWS6: Teva Pharmaceutical Remains Firmly Negative After Early Sell-Off.NEWS7: Teva Pharmaceutical Remains Firmly Negative After Early Sell-Off.NEWS8: 5 Blue Chip Drug Stocks Poised for Long-Term Gains.
2018-10-18: NEWS1: Pfizer’s Growth Rate and Estimates.NEWS2: Puma Biotech (PBYI) Rides High on Robust Nerlynx Performance.NEWS3: Puma Biotech (PBYI) Rides High on Robust Nerlynx Performance.NEWS4: Better Buy: GlaxoSmithKline plc vs. Eli Lilly.NEWS5: Better Buy: GlaxoSmithKline plc vs. Eli Lilly.NEWS6: Pfizer’s Market Cap and Shareholding Pattern.NEWS7: Better Buy: GlaxoSmithKline plc vs. Eli Lilly.NEWS8: Novo Nordisk (NVO) Faces Pricing Pressure and Competition.NEWS9: Novo Nordisk (NVO) Faces Pricing Pressure and Competition.NEWS10: See what the IHS Markit Score report has to say about Eli Lilly And Co..
2018-10-19: NEWS1: Cramer's lightning round: GoPro's stock could go higher on a 'good holiday season'.NEWS2: BMY vs. LLY: Which Stock Should Value Investors Buy Now?.NEWS3: BMY vs. LLY: Which Stock Should Value Investors Buy Now?.NEWS4: Alkermes Boasts Strong Portfolio and Impressive Pipeline.NEWS5: Alkermes Boasts Strong Portfolio and Impressive Pipeline.NEWS6: BMY vs. LLY: Which Stock Should Value Investors Buy Now?.NEWS7: Pfizer’s Dividends and Earnings Quality.NEWS8: See what the IHS Markit Score report has to say about Eli Lilly And Co..NEWS9: Pfizer Reported Revenue Growth in Global Markets.
2018-10-22: NEWS1: ACR 2018: Lilly Announces Positive Results for Two Phase 3 Studies of Taltz® (ixekizumab) in Ankylosing Spondylitis (Radiographic Axial Spondyloarthritis).NEWS2: A Preview Of Eli Lilly's Q3 Earnings.NEWS3: Pfizer: Analysts’ Recommendations on October 22.NEWS4: Pfizer: Analysts Expect Revenue Growth in Q3.NEWS5: See what the IHS Markit Score report has to say about Eli Lilly And Co..
2018-10-23: NEWS1: Pfizer-Lilly non-opioid drug helps reduce osteoarthritis pain.NEWS2: Complete Results from First Study in Ongoing Phase 3 Program for Tanezumab Demonstrated Significant Improvement in Pain and Function in Osteoarthritis Patients.NEWS3: This IBD Stock Of The Day Is Heading For Fourth Quarter Of Profitability.NEWS4: Notable ETF Inflow Detected - XLV, LLY, BMY, CVS.NEWS5: Notable ETF Inflow Detected - XLV, LLY, BMY, CVS.NEWS6: How Is Novartis Valued?.NEWS7: See what the IHS Markit Score report has to say about Eli Lilly And Co..NEWS8: Investor Expectations to Drive Momentum within Navios Maritime Partners LP, Alliance Data, Eli Lilly, CONVERGEONE HLD, Atkore International Group, and NantKwest — Discovering Underlying Factors of Influence.NEWS9: Why Nektar Therapeutics Crashed 17.2% Today.NEWS10: Why Nektar Therapeutics Crashed 17.2% Today.

Answer: Decrease